Abstract

The American Cancer Society estimates that 60,050 cases of endometrial cancer will be diagnosed in 2016 and that 10,470 will die from endometrial cancer during 2016. Since 1988, incidence rates have increased by 1.3 per cent per year for women under 50 and by 1.9 per cent per year. In women age 50 and older, uterine cancers are usually treated with surgery, radiation, hormones, and/or chemotherapy. Uterine cancer is the most common form of gynecologic cancer. Surgery is the mainstay for staging and optimizing treatment for women with endometrial carcinoma. The surgical approach has evolved rapidly since the late 1980s with the introduction of laparoscopy in the surgical staging of endometrial cancer. An alternative to conventional laparoscopy or robotic surgery is single-port Laparoendoscopic 3-incision surgery which further enhances the cosmetic benefits of minimally invasive surgery, avoiding the potential morbidity associated with multiple incisions. Since it has been observed that it offers greater visibility and accuracy of the area of operation. Althoughmost of the advantages are in cases, such as patients with previous abdominal surgeries and obesity

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call